Niagen Bioscience
NAGE
65 hedge funds and large institutions have $54.7M invested in Niagen Bioscience in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 11 closing their positions.
138% more call options, than puts
Call options by funds: $114K | Put options by funds: $48K
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
20% more capital invested
Capital invested by funds: $45.8M → $54.7M (+$8.97M)
8% more funds holding
Funds holding: 60 → 65 (+5)
1.76% more ownership
Funds ownership: 19.55% → 21.32% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$714K |
| 2 |
BlackRock
New York
|
+$541K |
| 3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$445K |
| 4 |
State Street
Boston,
Massachusetts
|
+$291K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$234K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$608K |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$276K |
| 3 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$177K |
| 4 |
Renaissance Technologies
New York
|
-$157K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$126K |
NAGE Hedge Fund Activity: Q4 2019 in Review
65 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q4 2019, worth a combined $54.7M — up 20% from $45.8M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NAGE positions and 11 closed out — a net gain of 5 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Millennium Management, exiting entirely with an estimated $608K sold.
- 65 institutional investors held Niagen Bioscience (NAGE) as of Q4 2019, up from 60 in Q3 2019.
- Funds reported $54.7M of Niagen Bioscience stock for Q4 2019, up 20% quarter-over-quarter.
- 16 funds opened new Niagen Bioscience positions in Q4 2019 and 11 closed out, a net change of +5 holders.
- The largest Niagen Bioscience buyer in Q4 2019 was Vanguard Group, an estimated $714K added.
- The largest Niagen Bioscience seller in Q4 2019 was Millennium Management, an estimated $608K sold.
Based on aggregated 13F filings for Q4 2019.